ANIX

Anixa Biosciences Inc

Insiders buying nowCIK 715446

Anixa Biosciences Inc insider trading

Anixa Biosciences Inc is on this site because an insider bought its stock on the open market in the last 30 days. Every open-market purchase and sale its officers, directors and 10% owners filed in that time is listed below, each linked to the original Form 4.

From SEC filings · last 30 days

Recent ANIX insider transactions

The filing store could not be read just now — this page tries again on its next refresh. The filings themselves are on SEC EDGAR.

SEC Form 4 data, Q3 2024 to Q2 2026

ANIX insider trading by quarter

Between Jul 01, 2024 and Jun 30, 2026, 4 insiders traded ANIX on the open market: 22 purchases worth $540.9K and 0 sales. In the last four quarters alone: 8 purchases ($201.1K) and 0 sales, by 3 insiders.

QuarterBoughtSold
Q2 2026+$60K2 buys—
Q1 2026+$30.4K1 buy—
Q4 2025——
Q3 2025+$110.7K5 buys—
Q2 2025+$28.5K1 buy—
Q1 2025+$186K8 buys—
Q4 2024——
Q3 2024+$125.3K5 buys—
Largest purchase
+$95.9K of ANIX by Kumar Amit (Chief Executive Officer) on Jan 15, 2025.

Open-market transactions through Jun 30, 2026most recent first

  • Titterton Lewis H jr

    Director

    +$7.5K

    Jun 16, 2026

    2,836 sh · $2.64

  • Kumar Amit

    Chief Executive Officer · Director

    +$52.5K

    Jun 12, 2026

    21,000 sh · $2.50

  • Baskies Arnold M

    Director

    +$30.4K

    Jan 28, 2026

    10,000 sh · $3.04

  • Titterton Lewis H jr

    Director

    +$30.8K

    Jul 31, 2025

    10,000 sh · $3.08

  • Kumar Amit

    Chief Executive Officer

    +$15.8K

    Jul 30, 2025

    5,000 sh · $3.16

  • Baskies Arnold M

    Director

    +$17K

    Jul 18, 2025

    5,000 sh · $3.39

  • Titterton Lewis H jr

    Director

    +$31.4K

    Jul 11, 2025

    10,000 sh · $3.14

  • Kumar Amit

    Chief Executive Officer

    +$15.8K

    Jul 11, 2025

    5,000 sh · $3.15

  • Kumar Amit

    Chief Executive Officer

    +$28.5K

    Jun 04, 2025

    10,000 sh · $2.85

  • Baskies Arnold M

    Director

    +$14.1K

    Jan 28, 2025

    5,000 sh · $2.82

  • Titterton Lewis H jr

    Director

    +$3K

    Jan 24, 2025

    1,000 sh · $3.00

  • Titterton Lewis H jr

    Director

    +$5.8K

    Jan 23, 2025

    2,000 sh · $2.91

  • Titterton Lewis H jr

    Director

    +$6K

    Jan 22, 2025

    2,000 sh · $3.01

  • Titterton Lewis H jr

    Director

    +$15.5K

    Jan 21, 2025

    6,000 sh · $2.59

  • Titterton Lewis H jr

    Director

    +$25.7K

    Jan 17, 2025

    10,000 sh · $2.57

From SEC's quarterly Form 3, 4 and 5 data sets: code P purchases and code S sales of common stock, by the date the trade happened. Where a fund and the people who control it each report the same block, it is counted once. Trades made in the last days of Q2 2026 but filed after it closed arrive with SEC's next quarterly release.

Don't check ANIX — let it ping you

Watch every insider filing the minute it clears the SEC

The live dashboard reads every Form 4 as it lands and puts it in plain English — open-market buys, cluster buys where several insiders move at once, and the sales executives chose to make rather than scheduled. Free to open; Pro adds alerts, watchlists and each buyer's track record.

Anixa Biosciences Inc is outside the 777 companies InsiderPulse scans continuously. This page is built from the filings on the live tape and stays up while its insiders are buying. Monitoring, not advice.

Other companies insiders are buying now

Questions

How much ANIX stock have insiders bought and sold in the last two years?
Between Jul 01, 2024 and Jun 30, 2026, 4 Anixa Biosciences Inc insiders made 22 open-market purchases worth $540.9K and no sales. In the four quarters to Jun 30, 2026: 8 purchases ($201.1K) and no sales. The largest purchase was Kumar Amit buying $95.9K on Jan 15, 2025.
Where does ANIX insider trading data come from?
From the Form 4 filings Anixa Biosciences Inc's officers, directors and 10% owners must send the SEC within two business days of a trade. Each row on this page links to its original filing on SEC EDGAR. Share grants and option exercises are kept apart from open-market purchases and sales, because only the latter cost the insider their own money.

Get the free Insider Brief

Each weekday evening: the day's biggest open-market insider buys, cluster formations and 10b5-1 plan breaks — in plain English, with grants and routine vesting stripped out. Honest about what the data can and cannot say.

No account needed. One-click unsubscribe.